OpenURL Connection Search

Select item for more details and to access through your institution.

Cryoablation and immunotherapy: an overview of evidence on its synergy.
Published in:
Insights into Imaging, 2019, v. 10, n. 1, p. 1, doi. 10.1186/s13244-019-0727-5
By:
- Aarts, B. M.;
- Klompenhouwer, E. G.;
- Rice, S. L.;
- Imani, F.;
- Baetens, T.;
- Bex, A.;
- Horenblas, S.;
- Kok, M.;
- Haanen, J. B. A. G.;
- Beets-Tan, R. G. H.;
- Gómez, F. M.
Publication type:
Article
Cryoablation and immunotherapy: an overview of evidence on its synergy.
Published in:
Insights into Imaging, 2019, v. 10, n. 1, p. 1, doi. 10.1186/s13244-019-0727-5
By:
- Aarts, B. M.;
- Klompenhouwer, E. G.;
- Rice, S. L.;
- Imani, F.;
- Baetens, T.;
- Bex, A.;
- Horenblas, S.;
- Kok, M.;
- Haanen, J. B. A. G.;
- Beets-Tan, R. G. H.;
- Gómez, F. M.
Publication type:
Article
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.
Published in:
2016
By:
- De Groot, S.;
- Sleijfer, S.;
- Redekop, W. K.;
- Oosterwijk, E.;
- Haanen, J. B. A. G.;
- Kiemeney, L. A. L. M.;
- Uyl-de Groot, C. A.
Publication type:
journal article
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
Published in:
Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 926, doi. 10.1007/s00262-005-0677-2
By:
- Kerst, J. M.;
- Bex, A.;
- Mallo, H.;
- Dewit, L.;
- Haanen, J. B. A. G.;
- Boogerd, W.;
- Teertstra, H. J.;
- de Gast, G. C.
Publication type:
Article
HLA Class-II-restricted<em> Mycobacterium leprae</em>-reactive T-Cell Clones from Leprosy Patients Established with a Minimal Requirement for Autologous Mononuclear Cells.
Published in:
Scandinavian Journal of Immunology, 1986, v. 23, n. 1, p. 101, doi. 10.1111/j.1365-3083.1986.tb01947.x
By:
- Haanen, J. B. A. G.;
- Ottenhoff, T. H. M.;
- Voordouw, A.;
- Elferink, B. G.;
- Klatser, P. R.;
- Spits, H.;
- De Vries, R. R. P.
Publication type:
Article
Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma F. A. Vyth-Dreese et al. NK T cells in renal cell carcinoma.
Published in:
Clinical & Experimental Immunology, 2010, v. 162, n. 3, p. 447, doi. 10.1111/j.1365-2249.2010.04274.x
By:
- Vyth-Dreese, F. A.;
- Sein, J.;
- Van De Kasteele, W.;
- Dellemijn, T. A. M.;
- Van Den Bogaard, C.;
- Nooijen, W. J.;
- De Gast, G. C.;
- Haanen, J. B. A. G.;
- Bex, A.
Publication type:
Article
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2014, v. 110, n. 10, p. 2441, doi. 10.1038/bjc.2014.194
By:
- Lankheet, N A G;
- Kloth, J S L;
- Gadellaa-van Hooijdonk, C G M;
- Cirkel, G A;
- Mathijssen, R H J;
- Lolkema, M P J K;
- Schellens, J H M;
- Voest, E E;
- Sleijfer, S;
- de Jonge, M J A;
- Haanen, J B A G;
- Beijnen, J H;
- Huitema, A D R;
- Steeghs, N
Publication type:
Article
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
Published in:
2010
By:
- van der Veldt, A. A. M.;
- Meijerink, M. R.;
- van den Eertwegh, A. J. M.;
- Haanen, J. B. A. G.;
- Boven, E.
Publication type:
journal article
Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Published in:
2009
By:
- van der Veldt, A. A. M.;
- Boven, E.;
- van den Eertwegh, A. J. M.;
- Haanen, J. B. A. G.
Publication type:
Letter
Targeting dendritic cells with antigen via dendritic cell-associated promoters.
Published in:
Cancer Gene Therapy, 2012, v. 19, n. 5, p. 303, doi. 10.1038/cgt.2012.2
By:
- Moulin, V;
- Morgan, M E;
- Eleveld-Trancikova, D;
- Haanen, J B A G;
- Wielders, E;
- Looman, M W G;
- Janssen, R A J;
- Figdor, C G;
- Jansen, B J H;
- Adema, G J
Publication type:
Article
Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 6, p. 447, doi. 10.1007/s00280-023-04517-8
By:
- Groenland, Stefanie L.;
- Janssen, J. M.;
- Nijenhuis, C. M.;
- de Vries, N.;
- Rosing, H.;
- Wilgenhof, S.;
- van Thienen, J. V.;
- Haanen, J. B. A. G.;
- Blank, C. U.;
- Beijnen, J. H.;
- Huitema, A. D. R.;
- Steeghs, N.
Publication type:
Article
Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients.
Published in:
Journal of Clinical Pharmacology, 2017, v. 57, n. 1, p. 125, doi. 10.1002/jcph.788
By:
- Nijenhuis, C. M.;
- Huitema, A. D. R.;
- Blank, C.;
- Haanen, J. B. A. G.;
- Thienen, J. V.;
- Rosing, H.;
- Schellens, J. H. M.;
- Beijnen, J. H.
Publication type:
Article
Azathioprine-induced pure red-cell aplasia.
Published in:
Nephrology Dialysis Transplantation, 1996, v. 11, n. 7, p. 1371, doi. 10.1093/oxfordjournals.ndt.a027561
By:
- Pruijt, J. F. M.;
- Haanen, J. B. A. G.;
- Hollander, A. A. M. J.;
- den Ottolander, G. J.
Publication type:
Article
Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial.
Published in:
BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10457-y
By:
- Borgers, J. S. W.;
- Burgers, F. H.;
- Terveer, E. M.;
- van Leerdam, M. E.;
- Korse, C. M.;
- Kessels, R.;
- Flohil, C. C.;
- Blank, C. U.;
- Schumacher, T. N.;
- van Dijk, M.;
- Henderickx, J. G. E.;
- Keller, J. J.;
- Verspaget, H. W.;
- Kuijper, E. J.;
- Haanen, J. B. A. G.
Publication type:
Article
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Published in:
2008
By:
- van der Veldt, A A M;
- Boven, E;
- Helgason, H H;
- van Wouwe, M;
- Berkhof, J;
- de Gast, G;
- Mallo, H;
- Tillier, C N;
- van den Eertwegh, A J M;
- Haanen, J B A G
Publication type:
journal article

Found: 15